(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RARECELLS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RARECELLS

ST13

US500000079096167

Class

5, 9, 10, 42

Filing

79096167

Registration

4251972

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

56

Latest update

03/25/2024

Trademark type

Combined

Nice classes

5, 9, 10, 42

Filing date

03/30/2011

Registration date

12/04/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/17/2023

Last transaction

06/17/2023

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

FR

Examiner

LEASER, ANDREW

Law office

M30

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of a design of a drop that is white, gray and black on the top and red on the bottom and the same drop contains a design of a white, gray and black cell represented by two concentric circular shapes. To the right of the drop design is the wording "RARECELLS" in gray and underneath is a straight horizontal gray line that bisects through the drop design and ends with a red arrow tip.

Holders and representatives

Holders

NARADA
RARECELLS

Representatives

Robert C. Cumbow Miller Nash LLP

Technical classification

Nice Classes

Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical purposes ; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms; blood plasma; blood for medical purposes; vaccines

Class 9

Diagnostic apparatus for laboratory or research usediagnostic apparatus for testing foodfor testing of biological fluids and liquidsfor detecting pathogensdiaphragms specially adapted for use with the foregoing

Class 10

Diagnostic apparatus for medical purposesdiagnostic apparatus for the detection of cancergenetic diseasescardiological diseasesinfectious diseases

Class 42

Biological researchbacteriological researchchemical researchcosmetics researchmechanical researchtechnical research in the fields of blood and/or cell and/or tissue sample preparation and testing

Publications

History of USPTO decisions and trademark events.

56 publications found

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

03/25/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/28/2024

INPC

INVALIDATION PROCESSED

02/28/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

02/17/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/28/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/17/2023

71AG

REGISTERED-SEC.71 ACCEPTED

06/17/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/16/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/09/2022

ES71

TEAS SECTION 71 RECEIVED

12/01/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

12/04/2021

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

04/27/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/27/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

04/22/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

04/11/2021

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

01/14/2019

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

01/14/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/09/2019

ES75

TEAS SECTION 71 & 15 RECEIVED

11/15/2018

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/04/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/16/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/08/2013

FIMP

FINAL DISPOSITION PROCESSED

03/08/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/04/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

12/04/2012

GPNX

NOTIFICATION PROCESSED BY IB

10/14/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/18/2012

PUBO

PUBLISHED FOR OPPOSITION

09/18/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/29/2012

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/29/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/29/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/10/2012

ALIE

ASSIGNED TO LIE

08/09/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/27/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

07/27/2012

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/27/2012

GNEA

EXAMINERS AMENDMENT E-MAILED

07/27/2012

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/27/2012

DOCK

ASSIGNED TO EXAMINER

07/27/2012

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/30/2012

GNFR

FINAL REFUSAL E-MAILED

01/30/2012

CNFR

FINAL REFUSAL WRITTEN

01/30/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/05/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/28/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/28/2011

RFNT

REFUSAL PROCESSED BY IB

07/25/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/05/2011

RFRR

REFUSAL PROCESSED BY MPU

07/05/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/03/2011

CNRT

NON-FINAL ACTION WRITTEN

07/02/2011

DOCK

ASSIGNED TO EXAMINER

06/27/2011

MAFR

APPLICATION FILING RECEIPT MAILED

05/14/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/10/2011

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/05/2011

Continuous trademark protection

Get notified about every new filing that threatens RARECELLS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.